Pink Ribbons, Inc. (2012)

Theatrical Performance
Domestic Box Office $26,608Details
Further financial details...

Synopsis

The ubiquitous pink ribbons of breast cancer philanthropy—and the hand-in-hand marketing of brands and products associated with that philanthropy—permeates our culture, providing assurance that we are engaged in a successful battle against this insidious disease. But the campaign obscures the reality and facts of breast cancer—more and more women are diagnosed with breast cancer every year, and face the same treatment options they did 40 years ago. Yet women are also the most influential market group, buying 80 percent of consumer products and making most major household purchasing decisions. So then who really benefits from the pink ribbon campaigns—the cause or the company? And what if the very companies and products that profit from their association have actually contributed to the problem?

Metrics

Opening Weekend:$2,721 (10.2% of total gross)
Legs:9.78 (domestic box office/biggest weekend)
Domestic Share:100.0% (domestic box office/worldwide)
Production Budget:$1,200,000 (worldwide box office is 0.0 times production budget)
Theater counts:3 opening theaters/4 max. theaters, 6.3 weeks average run per theater
Infl. Adj. Dom. BO $39,982

Movie Details

Domestic Releases: June 1st, 2012 (Limited) by First Run Features
Video Release: September 25th, 2012 by First Run Home
MPA Rating: Not Rated
Running Time: 98 minutes
Cast, crew, or production detail: Agitprop
Plot point: Cancer, Terminal Illness
Source:Based on Real Life Events
Genre:Documentary
Production Method:Live Action
Creative Type:Factual
Production/Financing Companies: National Film Board of Canada
Production Countries: Canada
Languages: English

Weekend Box Office Performance

DateRankGross% ChangeTheatersPer TheaterTotal GrossWeek
Jun 1, 2012 88 $2,721   3 $907   $2,721 1
Jun 8, 2012 88 $2,463 -9% 3 $821   $7,353 2
Jun 22, 2012 85 $1,445   3 $482   $11,034 4
Jun 29, 2012 77 $2,153 +49% 4 $538   $14,621 5
Jul 6, 2012 84 $1,285 -40% 2 $643   $17,617 6
Jul 13, 2012 90 $194 -85% 2 $97   $18,762 7
Jul 20, 2012 86 $815 +320% 2 $408   $19,704 8
Jul 27, 2012 77 $2,134 +162% 3 $711   $22,568 9
Aug 3, 2012 94 $299 -86% 1 $299   $24,784 10
Aug 24, 2012 105 $165   2 $83   $25,677 13

Weekly Box Office Performance

DateRankGross% ChangeTheatersPer TheaterTotal GrossWeek
Jun 1, 2012 84 $4,889   3 $1,630   $4,889 1
Jun 8, 2012 90 $4,076 -17% 3 $1,359   $8,966 2
Jun 22, 2012 85 $2,879   3 $960   $12,468 4
Jun 29, 2012 78 $3,864 +34% 4 $966   $16,332 5
Jul 6, 2012 80 $2,236 -42% 2 $1,118   $18,568 6
Jul 13, 2012 92 $321 -86% 2 $161   $18,889 7
Jul 20, 2012 81 $1,545 +381% 2 $773   $20,434 8
Jul 27, 2012 73 $4,051 +162% 4 $1,013   $24,485 9
Aug 3, 2012 97 $647 -84% 1 $647   $25,132 10
Aug 10, 2012 96 $380 -41% 1 $380   $25,512 11
Aug 24, 2012 98 $917   4 $229   $26,429 13
Sep 7, 2012 106 $179   1 $179   $26,608 15

Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue are available through our research services. For more information, please contact us at research@the-numbers.com.


Synopsis

The ubiquitous pink ribbons of breast cancer philanthropy—and the hand-in-hand marketing of brands and products associated with that philanthropy—permeates our culture, providing assurance that we are engaged in a successful battle against this insidious disease. But the campaign obscures the reality and facts of breast cancer—more and more women are diagnosed with breast cancer every year, and face the same treatment options they did 40 years ago. Yet women are also the most influential market group, buying 80 percent of consumer products and making most major household purchasing decisions. So then who really benefits from the pink ribbon campaigns—the cause or the company? And what if the very companies and products that profit from their association have actually contributed to the problem?

Metrics

Opening Weekend:$2,721 (10.2% of total gross)
Legs:9.78 (domestic box office/biggest weekend)
Domestic Share:100.0% (domestic box office/worldwide)
Production Budget:$1,200,000 (worldwide box office is 0.0 times production budget)
Theater counts:3 opening theaters/4 max. theaters, 6.3 weeks average run per theater
Infl. Adj. Dom. BO $39,982

Movie Details

Domestic Releases: June 1st, 2012 (Limited) by First Run Features
Video Release: September 25th, 2012 by First Run Home
MPA Rating: Not Rated
Running Time: 98 minutes
Cast, crew, or production detail: Agitprop
Plot point: Cancer, Terminal Illness
Source:Based on Real Life Events
Genre:Documentary
Production Method:Live Action
Creative Type:Factual
Production/Financing Companies: National Film Board of Canada
Production Countries: Canada
Languages: English

Weekend Box Office Performance

DateRankGross% ChangeTheatersPer TheaterTotal GrossWeek
Jun 1, 2012 88 $2,721   3 $907   $2,721 1
Jun 8, 2012 88 $2,463 -9% 3 $821   $7,353 2
Jun 22, 2012 85 $1,445   3 $482   $11,034 4
Jun 29, 2012 77 $2,153 +49% 4 $538   $14,621 5
Jul 6, 2012 84 $1,285 -40% 2 $643   $17,617 6
Jul 13, 2012 90 $194 -85% 2 $97   $18,762 7
Jul 20, 2012 86 $815 +320% 2 $408   $19,704 8
Jul 27, 2012 77 $2,134 +162% 3 $711   $22,568 9
Aug 3, 2012 94 $299 -86% 1 $299   $24,784 10
Aug 24, 2012 105 $165   2 $83   $25,677 13

Weekly Box Office Performance

DateRankGross% ChangeTheatersPer TheaterTotal GrossWeek
Jun 1, 2012 84 $4,889   3 $1,630   $4,889 1
Jun 8, 2012 90 $4,076 -17% 3 $1,359   $8,966 2
Jun 22, 2012 85 $2,879   3 $960   $12,468 4
Jun 29, 2012 78 $3,864 +34% 4 $966   $16,332 5
Jul 6, 2012 80 $2,236 -42% 2 $1,118   $18,568 6
Jul 13, 2012 92 $321 -86% 2 $161   $18,889 7
Jul 20, 2012 81 $1,545 +381% 2 $773   $20,434 8
Jul 27, 2012 73 $4,051 +162% 4 $1,013   $24,485 9
Aug 3, 2012 97 $647 -84% 1 $647   $25,132 10
Aug 10, 2012 96 $380 -41% 1 $380   $25,512 11
Aug 24, 2012 98 $917   4 $229   $26,429 13
Sep 7, 2012 106 $179   1 $179   $26,608 15

Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue are available through our research services. For more information, please contact us at research@the-numbers.com.